Forest, VA, United States of America

Christopher Sean Fewox

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Christopher Sean Fewox: Pioneering Technologies in Radiopharmaceuticals

Introduction

Christopher Sean Fewox, an inventive mind based in Forest, Virginia, has made significant contributions to the field of radiopharmaceuticals. With a strong portfolio that includes three patents, Fewox’s work primarily focuses on advancing technologies that enhance the reliability and efficiency of medical imaging.

Latest Patents

Fewox's latest innovations include the following patents:

1. **Coaxial Needle Technetium Elution Generator**: This elution generator features a unique design with an elution column that has a container defining an interior volume and includes a septum. A radiation shield is equipped with an upper shield portion, which has a central recess, and a coaxial flow needle that extends downward into this recess. Additionally, the lower shield portion contains a body that also defines a central recess. The elution column is specifically integrated into the central recess of the lower shield, enhancing efficiency and precision in elution processes.

2. **System and Method for Evaluating Elution Efficiency and Radiopurity of Tc-99m Generators**: This innovative system provides a way to analyze the radiochemical purity of an eluate produced from a Technetium-99m (Tc-99m) generator. The system is equipped with an elution detector made from shielding metal that houses a flow path template, allowing for effective monitoring of both the generator and the eluate solution. This apparatus is essential for ensuring the reliability of radioactive isotopes used in medical applications.

Career Highlights

Christopher Sean Fewox is a prominent team member at BWXT Isotope Technology Group, Inc., where he contributes to the development of advanced isotopic technologies. His extensive experience in radiopharmaceuticals has earned him recognition in the scientific community, as he continually works on improving medical imaging techniques and ensuring patient safety.

Collaborations

Throughout his career, Fewox has had the privilege of collaborating with talented professionals such as Bryan Blake Wiggins and Earl Brian Barger. These collaborations have driven innovation within the company and have led to the development of cutting-edge technologies that are shaping the future of radiopharmaceuticals.

Conclusion

Christopher Sean Fewox stands out as an influential inventor in the field of radiopharmaceuticals. His three innovative patents not only demonstrate his commitment to advancing medical technology but also highlight the importance of collaboration in fostering innovation. As he continues to work with BWXT Isotope Technology Group, Inc., his contributions are poised to make a lasting impact on the medical imaging landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…